Detection of germline BRCA1 mutations in breast cancer patients by quantitative messenger RNA in situ hybridization

Cancer Research

Volumn 56, Issue 13, 1996, Pages 2912-2915

  Kainu, Tommi ^a   Kononen, Juha ^a   Johansson, Oskar ^b   Olsson, Håkan ^b   Borg, Åke ^b   Isola, Jorma ^a,c  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b LUND UNIVERSITY   (Sweden)

^c UNIVERSITY OF TAMPERE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; GENE MUTATION; GENETIC LINKAGE; HUMAN; IN SITU HYBRIDIZATION; MOLECULAR CLONING; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS;

ADULT; AGED; BRCA1 PROTEIN; BREAST NEOPLASMS; FEMALE; GENETIC MARKERS; GERM-LINE MUTATION; HUMANS; IN SITU HYBRIDIZATION; MIDDLE AGED; NEOPLASM PROTEINS; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 0029936995     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Miki, Y , Swensen, J., Shattuck-Eidens, D., Futreal, A., Harshman, K., Tavtigian, S , Liu, Q., Cochran, C., Bennett, L. M., Ding, W , Bell, R., Rosenthal, J., Hussey, C., Tran, T., McClure, M., Frye, C , Hattier, T , Phelps, R., Haugen-Strano, A., Katcher, H., Yakumo, K., Glomani, Z., Shaffer, D. Stone, S , Bayer, S , Wray, C., Bogden, R., Dayananth, P , Ward, J , Tonin, P , Narod, S., Bristow, P K., Norris, F. H., Helvering, L., Morrison, P., Rosteck, P., Lai, M., Barrett, J C., Lewis, C., Neuhausen, S., Cannon-Albright, L., Goldgar, D., Wideman, R., Kamb, A , and Skolnick, M. H A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science (Washington DC),266: 66-71, 1994.
2. Szabo, C. I., and King, M-L. Inherited breast and ovarian cancer. Hum. Mol Genet., 4: 1811-1817, 1995.
3. Struewing, J. P , Abeliovich, D., Peretz, T , Avishai, N., Kaback, M. M., Collins, F. S., and Brody, L. C. The carrier frequency of the BRCA1 185delAG mutation is approximately 1% in Askhenazi Jewish individuals Nat. Genet., 11: 198-200, 1995.
4. Futreal, P. A., Liu, Q., Shattuck-Eidens, D., Cochran, C., Harshman, K , Tavtigian, S., Bennett, L. M., Haugen-Strano, A , Swensen, J , and Miki, Y BRCA1 mutations in primary breast and ovarian carcinomas. Science (Washington DC), 266: 120-122, 1994.
5. Shattuck-Eidens, D , McClure, M , Simard, J., Labrie, F., Narod, S. Couch, F., Hoskins, K., Weber, B., Castilla, L., and Erdos, M. A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene, implications for presymptomatic testing and screening. J. Am. Med. Assoc , 273: 535-541, 1995.
6. Ross, J. mRNA stability in mammalian cells. Microbiol. Rev , 59: 423-450, 1995.
7. Chen, Y., Chen, C-F., Riley, D. J., Allred, D C., Chen, P-L., Von Hoff, D , Osborne, K., and Lee, W-H., Aberrant subcellular localization of BRCA1 in breast cancer. Science (Washington DC), 270. 789-791, 1995.
8. Johansson, O., Ostermeyer, E. A., Håkansson, S., Friedman, L. S., Johansson, U., Sellberg, G., Brøndum-Nielsen, K., Sele, V., Olsson, H., King, M-C., and Borg, Å. Founding BRCA1 mutations in hereditary breast and ovarian cancer from South Sweden. Am. J Hum. Genet., 58: 441-450, 1996.
9. Marquis, S. T., Rajan, J. V., Wynshaw-Boris, A., Junzhe, X., Yin, G-Y., Abel, K. J., Weber, B. L., and Chodosh, L. A. The developmental pattern of BRCA1 expression implies a role in differentiation of the breast and other tissues Nat. Genet., 11: 17-26. 1995
10. Thompson, M. E., Jensen, R. A., Obermiller, P. S., Page, D. L., and Holt, J. T. Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat. Genet., 9: 444-450, 1995.
11. Smith, S. A., Easton, D. F., Evans, D. G R., and Ponder, B. A. J Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome. Nat. Genet., 2. 121-131, 1992
12. Cui, Y., Hagan, K W., Zhang, S., and Peltz, S. W. Identification and characterization of genes that are required for the accelerated degradation of mRNA's containing a premature translation termination codon. Genes Dev., 9. 423-436, 1995.
13. Serova, O., Montagna, M., Torchard, D., Narod, S. A., Tonin, P., Sylla, B., Lynch, H. T , Feunteun, J., and Lenoir, G. M. A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families. Am. J Hum. Genet , 53: 42-51, 1996.
14. Dunn, J. M., Phillips, R. A., Zhu, X , Becker, A., and Gallie, B. L. Mutations in the RBI gene and their effects on transcription. Mol. Cell. Biol., 9: 4596-4604, 1989
15. Smith, K. J., Johnson, K. A., Bryan, T. M., Hill, D E., Markowitz, S., Wilson, J. K V , Paraskeva, C., Petersen, G M , Hamilton, S R., Vogelstein, B., and Kinzler, K. W. The APC gene product in normal and tumor cells Proc. Natl Acad. Sci. USA, 90: 2846-2850, 1993
16. Comelis, R. S., Vasen, H F. A., Meijers-Heijbor, H., Ford, D., vanVliet, M., van Tilborg, A. A. G., Cleton, F. J., Klijn, J. G. M., Menko, F. H., Meera Kahn, P., Comelisse, C. J., and Devilee, P. Age at diagnosis as an indicator of eligibility for BRCA1 DNA testing in familial breast cancer. Hum Genet., 95: 539-544, 1995.